![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, June 17, 2021 10:25:23 PM
We explore deeper to find the best biomarkers
Our KEM® platform is the only FDA-tested technology that explores the entire combinatorial space, and guides you to the most cost-effective biomarkers
We look closer to maximize clinical trial success rates
Our FDA-tested KEM® technology helps secure product approval .
We discover more with KEM®
KEM®, our Artificial Intelligence, finds hidden signals and complex relationships that conventional statistical analyses miss.
We Fast-track your clinical trials
We identify best Responders and optimal Endpoints.
Precision Medicine
KEM Services: we have a track record of helping clients increase value of their clinical assets
Design clinical protocols to include Precision Medicine
Collect samples and generate omic data (DNA, RNA, Micro biota)
Use our KEM® Artificial Intelligence platform to perform combined analysis and patient stratification
Identify:
best responders,
best companion biomarkers,
best drug combinations,
best end-points
Define a regulatory strategy and present to the FDA
https://www.arianapharma.com/
Good luck and GOD bless,
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM